Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 45 - Medicinal preparations containing active ingredients not provided for in groups
Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
12/2000
12/14/2000CA2376400A1 Compounds and methods to enhance raav transduction
12/14/2000CA2376210A1 Therapeutic use of an inhibitor of a hedgehog or a hedgehog-related signalling pathway
12/14/2000CA2376175A1 Vitamin directed dual targeting therapy
12/14/2000CA2375912A1 Immunotherapy of autoimmune disorders using antibodies which target b-cells
12/14/2000CA2375876A1 An integrin heterodimer and an alpha subunit thereof
12/14/2000CA2375371A1 Oil-core compositions for the sustained release of hydrophobic drugs
12/14/2000CA2375149A1 Apo-2l receptor agonist and cpt-11 synergism
12/14/2000CA2374851A1 Tek antagonists
12/14/2000CA2374558A1 Phospholipid transfer protein
12/14/2000CA2374001A1 Alpha or beta emitters attached to fragments in radioimmunotherapy
12/14/2000CA2371434A1 Compositions and methods for the treatment of tumor
12/14/2000CA2337853A1 Drug releasing elastomeric ligating band
12/13/2000EP1059100A2 Combinations of CRF antagonists and renin-angiotensin system inhibitors
12/13/2000EP1059092A1 Use of complexes among cationic liposomes and polydeoxyribonucleotides as medicaments
12/13/2000EP1059091A1 Transmucous sorbefacients
12/13/2000EP1059090A1 Remedies for brain infarction
12/13/2000EP1059084A2 Rapidly absorbed liquid compositions containing an amine and a NSAID
12/13/2000EP1058737A1 Novel fdrg protein and nucleic acid molecules and uses therefor
12/13/2000EP1058691A1 Caspase-8 interacting proteins
12/13/2000EP1058562A1 Compositions and methods of treating tumors
12/13/2000EP1058559A1 Combination of a selective nmda nr2b antagonist and a cox-2 inhibitor
12/13/2000EP1058555A1 Costimulatory blockade and mixed chimerism in allotransplantation
12/13/2000EP1058551A1 Use of d1/d5 antagonists for treating obsessive compulsive disorders, somatoform disorders, dissociative disorders, eating disorders, impulse control disorders and autism
12/13/2000EP1058546A1 Composition and method for treating macular disorders
12/13/2000EP0927196A4 Polymers containing polysaccharides such as alginates or modified alginates
12/13/2000EP0802784B1 Nutrient medium for use as a culture medium for epidermal cells, and uses thereof
12/13/2000CN1276832A Composition and method for identifying PKB kinase inhibitors
12/13/2000CN1276729A Heparin-binding growth factor (HBGF) polypeptides
12/13/2000CN1276724A Eprosartan arginyl charge-neutralization-complex and process for its production and formulation
12/13/2000CN1276720A Formulations and method for reducing toxicity of antineoplastic agent
12/13/2000CN1276717A Glucose-contg. preparation
12/13/2000CN1276211A Use of non-peptides NK3-antagonist
12/13/2000CN1059446C Pharmaceutical composition and compounds for contraception, and their use
12/12/2000US6160108 Platelet activation protein
12/12/2000US6160099 Anti-human αv β3 and αv β5 antibodies
12/12/2000US6160094 Enzymatic polypeptide; for use as a wound healing agent; for use in dentistry to prevent of adhesion of bacteria in wounds
12/12/2000US6160088 Oligomeric lysine-aspartic acid-glutamic acid-leucine amino acid sequence binding protein suppressor; for amplification of immune response to secreted chaperone proteins
12/12/2000US6160024 Photoactivated antiviral and antitumor compositions
12/12/2000US6160021 Administering to the subject a treatment which modulates the level of nitric oxide in the skin
12/12/2000US6160020 Alkali metal and alkaline-earth metal salts of acetaminophen
12/12/2000US6160015 Administering to mammal a farnesyl protein transferase inhibitor
12/12/2000US6160007 Method for enhancing the absorption and transport of lipid soluble compounds using structured glycerides
12/12/2000US6159997 Treatment of arteriosclerosis and xanthoma
12/12/2000US6159977 Therapeutic anti-fungal nail preparation
12/12/2000US6159970 Enzyme inhibitors
12/12/2000US6159955 Use of hyaluronic acid and a NSAID for the manufacture of a medicament for the treatment of mucosal diseases
12/12/2000US6159953 Anti-malarial composition and method of use
12/12/2000US6159949 Polynucleotides, codes and amino acid sequences
12/12/2000US6159734 Nucleotide sequences which prevent or reduce transcription of human gene; for the treatment of non-insulin dependent diabetes, cardiovascular disorders and gastrointestinal disorders; antiinflammatory agents; anticarcinogenic agents
12/12/2000US6159732 Nucleic acid encoding mammalian Ubr1
12/12/2000US6159704 Phosphatase modulator
12/12/2000US6159500 Pharmaceutical preparations of glutathione and methods of administration thereof
12/12/2000US6159476 Herbal supplement for increased muscle strength and endurance for athletes
12/12/2000US6159458 Sustained release ophthalmic compositions containing water soluble medicaments
12/12/2000US6159443 X-ray guided drug delivery
12/12/2000CA2168247C Nitric oxide donor composition and method for treatment of anal disorders
12/11/2000CA2274419A1 Use of complexes among cationic liposomes and polydeoxyribonucleotides as medicaments
12/10/2000CA2311039A1 Rapidly absorbed liquid compositions
12/07/2000WO2000073801A2 Breast, gastric and prostate cancer associated antigens and uses therefor
12/07/2000WO2000073511A1 New mutational profiles in hiv-1 reverse transcriptase correlated with phenotypic drug resistance
12/07/2000WO2000073507A2 Identification of a novel retrovirus associated with primary biliary cirrhosis and autoimmune disorders
12/07/2000WO2000073481A1 Methods and compositions for lowering the level of tumor necrosis factor (tnf) in the tnf-associated disorders
12/07/2000WO2000073469A2 Protein kinases
12/07/2000WO2000073450A2 Cytoskeleton-associated proteins
12/07/2000WO2000073449A1 Dna encoding snorf33 receptor
12/07/2000WO2000073445A2 Interleukin-1-receptor associated kinase-3 (irak3)
12/07/2000WO2000073416A1 Antisense oligonucleotides for fertility and menstrual cycle regulation and for chemopreventive and chemotherapeutic use
12/07/2000WO2000073348A2 Methods and compositions for inhibiting neoplastic cell growth
12/07/2000WO2000073342A1 Structural models for cytoplasmic domains of transmembrane receptors
12/07/2000WO2000073335A1 Cytotoxic t-cell epitopes of the papilloma virus l1-protein and use thereof in diagnosis and therapy
12/07/2000WO2000073334A2 Human sorting nexins
12/07/2000WO2000073331A2 Use of exendins and agonists thereof for the treatment of gestational diabetes mellitus
12/07/2000WO2000073330A2 Method and compositions relating to insulin resistance disorders
12/07/2000WO2000073323A2 Adam polynucleotides and polypeptides
12/07/2000WO2000073321A1 Human tumor necrosis factor receptor tr10
12/07/2000WO2000073276A2 Carboxylic acid derivatives comprising aryl-substituted nitrogen heterocycles, their production and their use as endothelin receptor antagonists
12/07/2000WO2000073266A1 Novel antioxidants, preparation methods and uses
12/07/2000WO2000072885A2 Methods of inducing regulated pancreatic hormone production in non-pancreatic islet tissues
12/07/2000WO2000072876A2 Prevention and treatment of amyloidogenic disease
12/07/2000WO2000072865A2 Antifungal combination use
12/07/2000WO2000072863A2 Uses of h-trek-1 polypeptides and polynucleotides encoding them
12/07/2000WO2000072862A1 Cranberry seed oil extract and compositions containing components thereof
12/07/2000WO2000072859A1 Balsam for the treatment of surface burns and chafing rashes
12/07/2000WO2000072855A2 Dietary or pharmaceutical composition for use for the prevention or treatment of hyperoxaluria
12/07/2000WO2000072851A1 Method of sterilizing
12/07/2000WO2000072843A1 Therapeutic use of melatonin
12/07/2000WO2000072842A1 Nutritional supplements
12/07/2000WO2000072838A1 New use of compounds as antibacterial agents
12/07/2000WO2000072834A2 Agent for expression of long-term potentiation of synaptic transmission comprising compound having brain somatostatin activation property
12/07/2000WO2000072831A1 Nutritional formulations
12/07/2000WO2000072825A1 Novel formulations comprising lipid-regulating agents
12/07/2000WO2000072823A1 Preparations for the application of anti-inflammatory agents
12/07/2000WO2000072806A2 Sunscreen composition containing sol-gel microcapsules
12/07/2000WO2000072799A2 Method and compositions for treating the inflammatory response
12/07/2000WO2000072701A1 Method and composition for masking mineral taste
12/07/2000WO2000072666A2 USE OF TRANSGENIC MICE LACKING JunB EXPRESSION IN THE MYELOID LINEAGE
12/07/2000WO2000050565A3 Compositions, kits, and methods relating to the human fez1 gene, a novel tumor suppressor gene
12/07/2000WO2000049937A3 Trpm-2 antisense therapy
12/07/2000WO2000048583A3 Formulation of 5-ht agonists with nsaids, especially cox-2 inhibitors, for treating migraine
12/07/2000WO2000046391A3 Genes displaying enhanced expression during cellular senescence and terminal cell differentiation and uses thereof
1 ... 942 943 944 945 946 947 948 949 950 951 952 953 954 955 956 957 958 959 960 961 962 ... 1151